![Masahiro Hirano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Masahiro Hirano
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
TXP Medical, Inc.
![]() TXP Medical, Inc. Packaged SoftwareTechnology Services TXP Medical, Inc. specializes in providing patient information record and management systems for emergency hospitals. TXP Medical is based in Japan and was founded in 2017 by Tomohiro Sono. The Japanese company's products include Next Stage ER, a paperless system for efficient patient information records and information sharing among staff, Next Stage Oncology, a database system that improves the speed and quality of medical treatment and research, NSER Mobile, an emergency support app that digitizes emergency patient information and links information in the cloud, and an interview system that allows for collaboration and incorporation of electronic medical records. The company also offers a clinic and hospitalization support system for corona-infected patients and an acute clinical trial support service for pharmaceuticals and medical device manufacturers. The company has a rare research system that includes an academic research department gathering students and doctors from all over the country.
2
| Holding Company | Packaged Software | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Masahiro Hirano tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
The University of Tokyo Edge Capital Co. Ltd.
![]() The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | Investment Managers | Private Equity Investor | |
Elixirgen Therapeutics, Inc.
![]() Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Giappone | 2 |
Stati Uniti | 2 |
Settori
Finance | 2 |
Health Technology | 2 |
Posizioni
Director/Board Member | 3 |
Private Equity Investor | 1 |
Founder | 1 |
Contatti più connessi
Insiders | |
---|---|
Hiroaki Kobayashi | 3 |
Tomohiro Sono | 1 |
- Borsa valori
- Insiders
- Masahiro Hirano
- Connessioni Società